Wir verwenden standardmäßig essenzielle Cookies (Anmeldung, deine gespeicherten Ziele/Stacks). Mit deiner Erlaubnis aktivieren wir außerdem datenschutzfreundliche Analytik (Vercel Web Analytics, anonyme Ladezeit-Metriken) und Fehler-Replay-Diagnostik (Sentry — DOM-Snapshots nur, wenn ein Fehler auftritt), damit wir Bugs schneller beheben können. Mehr über Cookies erfahren
Hch7.0
Horse Chestnut – Forschung
Überwiegend Mechanismus / Beobachtung
19 begutachtete Studien
Was die Evidenz sagt
Überwiegend Mechanismus / Beobachtung
Die meisten Studien zu Horse Chestnut sind mechanistisch oder beobachtend statt RCTs, die einen klinischen Effekt messen — betrachte die Ergebnisse als vorläufig.
Die meiste Evidenz stammt aus hochwertigen Meta-Analysen und randomisierten Studien, veröffentlicht 1998–2026.
Basierend auf 19 Studien · 5 Meta-Analysen · 6 RCTs
Konfidenz
Hohe Konfidenz
Nach Outcome
Fertility & reproductive
Zu wenige bewertete Studien1 Studie
Stetige Forschung
4 Studien in den letzten 5 Jahren · Neueste Meta-Analyse: 2018
Escin, extracted from horse chestnut ( Aesculus hippocastanum ) has anti-edema and anti-inflammatory effects.
It is used to treat several clinical conditions, including venous insufficiency, pain, inflammation, and edema.
Considering escin's pharmacodynamic, the inhibition of the bradykinin pathway represents a particular effect, decreasing the local edema and conferring an advantage in comparison to other compounds.
Einfach gesagt: It covers the chemical makeup of these plant drugs, their pharmacological effects, results from clinical trials involving humans, and any associated safety concerns.
Bencsik T, Balázs VL, Farkas Á, Csikós E, Horváth A, Ács K, Kocsis M, Doseděl M, Fialová SB, Czigle S, Nagy M, Tóth J, Protti M, Mercolini L, Mladěnka P, Szentpéteri J, Horváth G. · Fitoterapia (2024)
The prevalence of chronic venous disease (CVD) is relatively high, it affects 20-80 % of the population worldwide.
Among therapeutic possibilities for CVD, mainly chronic venous insufficiency, some medicinal plants (Ruscus aculeatus L., Aesculus hippocastanum L., Centella asiatica (L.) Urb.) and their active compounds (ruscoside, aescin, asiaticoside) or close derivatives also have important places.
This review describes shortly the updated knowledge on pathophysiology, clinical manifestations, evaluation, and diagnostics of CVD as well as treatment modalities.
Einfach gesagt: The incorporation of these herbal therapies into clinical practice is a well-tolerated holistic approach to the management of hemorrhoids, which requires further investigation to gain evidence-based validation.
Admuthe NB, Karajgi S, Uikey J, Bhimraj NM, Prakash V, Babar TP, Karra T, Shrivastava R. · Cureus (2025)
Therapeutically notable plants such as witch hazel ( Hamamelis virginiana ), horse chestnut ( Aesculus hippocastanum ), and triphala have shown beneficial therapeutic effects on pain, bleeding, and swelling, as well as preventing recurrence.
Moreover, Triphala Guggulu and Pilex are polyherbal formulations that offer synergistic benefits in addition to foods rich in polyphenols and the dietary compound, rutin.
These promising findings have so far faced challenges related to the standardization, quality control, and clinical validation.
Einfach gesagt: While MPFF is referred to in these guidelines as a leading option, further research is needed to better understand how different VADs can be used most effectively in treating CVD.
Santiago FR et al. · Vascular pharmacology (2026)
MPFF demonstrated robust efficacy in randomized controlled trials, significantly reducing symptoms such as pain, leg heaviness, and edema, and improving QoL.
Other VADs, including rutosides, calcium dobesilate, and horse chestnut seed extract, have demonstrated clinical efficacy.
Different medical guidelines for treating CVD from around the world recommend using VADs, though with some discrepancies on recommendation gradings.